Mount Sinai’s Arnhold Institute for Global Health and NYC Health + Hospitals Announce 2022 Winners of CURE-19 Research Pilot Grants

Mount Sinai’s Arnhold Institute for Global Health and NYC Health + Hospitals Announce 2022 Winners of CURE-19 Research Pilot Grants

Winners will examine the impacts of COVID-19 on lung function, maternal and child health outcomes, underrepresented minority youth, and respiratory recovery

Sep 14, 2022

The Arnhold Institute for Global Health at Icahn School of Medicine at Mount Sinai and NYC Health+ Hospitals announced the 2022 recipients of the CURE-19 Research Pilot Grants, an initiative to support collaborative, interdisciplinary research on COVID- 19 which will address both the pandemic and root causes of health disparities in New York City. Each winner will receive up to $25,000 to support their Icahn Mount Sinai-funded research project.

The CURE-19 Research Pilot Grants, which were launched last year, will support new research on COVID-19, with a focus on projects related to disease control for large communities, informatics and decision support systems, addressing structural racism and social determinants of health, translational scientific research, and evidence-based interventions and policies. Projects will also address the long-term effects of COVID-19, the social and environmental determinants of COVID-19, and maternal and child health related to COVID-19.

“We are thrilled to support the second cohort of research studies as part of the CURE-19 collaboration with NYC Health + Hospitals to pursue groundbreaking research into the impact of COVID-19,” said CURE-19 Co-Director Rachel C. Vreeman, MD, MS, Chair of the Department of Global Health and Health Systems Design and Director of the Arnold Institute for Global Health. “The pandemic continues to exacerbate long-standing social, economic and health inequalities for vulnerable communities in New York and around the world. CURE-19 Research Pilot Grants help us develop and scale innovations that address these challenges. Ultimately, they will improve equitable care and strengthen our pandemic response for the most vulnerable.

“CURE-19 shows great promise for solving several puzzles brought about by the pandemic, especially those affecting vulnerable people, including children and underrepresented people,” said CURE-19 Co-Director Joseph Masci, MD, President of Global Health at NYC Health + Hospitals/Elmhurst and Professor of Medicine (Infectious Diseases) at Icahn Mount Sinai. “This is a welcome addition to the resources already dedicated to these issues. The broad scope of the four research projects we are funding this year reflects both the scale of the pandemic’s impact and the diverse ways we are working to meet the needs of our community.

The 2022 research grant recipients and their projects include:

  • Effects of COVID-19 on Underrepresented Minority Youth: Kara S. Bagot, MD, assistant professor of psychiatry and pediatrics at Icahn Mount Sinai, and her team will identify the psychosocial and health consequences of the pandemic, such as depression, anxiety and substance abuse, on underprivileged minorities. represented and people with a low socio-economic level. – young status; they will also develop intervention methods to improve the social and behavioral outcomes of these high-risk groups.
  • Impact of structural racism on maternal and child health during COVID-19: Alison Lee, MD, MS, associate professor of medicine (pulmonology, critical care and sleep medicine) and pediatrics, at Icahn Mount Sinai, and her team will examine how structural racism, such as segregated residential communities near environmental toxins , may contribute to maternal and child health disparities in the context of the COVID-19 pandemic; they will also study how structural racism increases the risk of infection with SARS-CoV-2, the virus that causes COVID-19, during pregnancy and the impact of racial/ethnic inequalities on health outcomes across the lifespan. of life.
  • Effects of music therapy for treating post-COVID respiratory symptoms: Joanne V. Loewy, DA, LCAT, MT-BC, director of the Louis Armstrong Center for Music and Medicine at Mount Sinai Health System, and her team will evaluate the effectiveness of clinical music therapy for treating adults previously diagnosed with COVID-19 who suffer from shortness of breath; they will use live music to focus on respiratory symptoms related to breath control and other symptoms including fatigue, sleep, depression and anxiety to determine the direct impact of playing instruments wind and singing to improve breathing strength – potentially a benefit for long-haul COVID-19.
  • Long-term impact of COVID-19 on lung function: Muhammad Khurram Perwaiz, MD, chief interventional pulmonology at NYC Health + Hospitals/Elmhurst, and his team will study COVID-19 recovery patterns to increase awareness of long-term effects on lung function by identifying risk factors that prohibit long term recovery and effective therapies to treat this condition; they will also contribute to the development of guidelines for effective post-discharge care, particularly for patients in an urban community hospital in an area serving vulnerable populations.

The research pilots are part of a larger partnership known as the COVID-19 Research Unit at NYC Health + Hospitals/Elmhurst and NYC Health + Hospitals/Queens (CURE-19), a collaboration between the Mount Sinai’s Arnhold Institute for Global Health and NYC Health + Hospitals’ Global Health Institute which was formed during the initial peak of the pandemic in 2020. CURE-19 reflects data, experiences and lessons from clinicians at Mount Sinai Health System , Elmhurst Hospital and Queens Hospital in research to both learn and respond to the global pandemic. Mount Sinai, Elmhurst, and Queens hospitals also have a long-standing academic affiliation agreement and joint residency programs, and have previously collaborated on training, patient care, and research. The Arnhold Institute for Global Health at Mount Sinai, which specializes in global health systems and implementation research, supports four strategic global partnerships that build more resilient health systems by leveraging academic partners and the health system to meet the needs of vulnerable populations.

About Mount Sinai Health System
Mount Sinai Health System is one of the largest academic medical systems in the New York metropolitan area, with more than 43,000 employees working in eight hospitals, more than 400 outpatient practices, nearly 300 laboratories, a nursing school and a large school of medicine and higher education. Mount Sinai advances health for everyone, everywhere, by addressing the most complex health challenges of our time – discovering and applying new knowledge and scientific knowledge; developing safer and more effective treatments; train the next generation of medical leaders and innovators; and supporting local communities by providing high quality care to all who need it.

Through the integration of its hospitals, laboratories and schools, Mount Sinai offers comprehensive healthcare solutions from birth to geriatrics, leveraging innovative approaches such as artificial intelligence and IT while keeping patients’ medical and emotional needs at the center of all treatments. The health system includes approximately 7,300 primary and specialty care physicians; 13 joint venture day surgery centers in the five boroughs of New York, Westchester, Long Island and Florida; and over 30 affiliated community health centers. We are regularly ranked by US News and World Report‘s Best Hospitals, receiving a high “Honor Roll” status, and are highly ranked: #1 in Geriatrics and top 20 in Cardiology/Cardiac Surgery, Diabetes/Endocrinology, Gastroenterology/Gastrointestinal Surgery, Neurology/Neurosurgery, orthopaedics, pulmonology/lung Surgery, rehabilitation and urology. New York Eye and Ear Infirmary of Mount Sinai is ranked #12 in ophthalmology. US News and World ReportMount Sinai Kravis Children’s Hospital’s “Best Hospitals for Children” ranking is one of the best in the country in several pediatric specialties. The Icahn School of Medicine at Mount Sinai is one of three medical schools that has distinguished itself by several indicators: it is consistently ranked in the top 20 by US News and World Report“Best Medical Schools”, aligned with a US News and World Report “Honor Roll” Hospital, and among the top 20 in the nation for funding from the National Institutes of Health and among the top 5 in the nation for many areas of basic and clinical research. NewsweekThe “World’s Best Smart Hospitals” ranks Mount Sinai Hospital number one in New York and among the top five in the world, and Mount Sinai Morningside in the top 20 globally.

For more information, visit or find Mount Sinai on Facebook, Twitter and YouTube.

About NYC Health + Hospitals
NYC Health + Hospitals is the nation’s largest municipal health care system, serving more than one million New Yorkers each year at more than 70 patient care facilities across the city’s five boroughs. A strong network of outpatient primary and specialty care centers based in the neighborhood anchors coordination of care with trauma centers, nursing homes, post-acute care centers, home care agency and plan MetroPlus health system, all supported by 11 essential hospitals. Its diverse workforce of more than 43,000 employees is uniquely focused on empowering New Yorkers, without exception, to live the healthiest lives possible. For more information, visit and stay connected on Facebook at or Twitter at @NYCHealthSystem.

Add Comment